HBV replication inhibitors (GVK Biosciences)

N/A

Report date: 2025/03/20 15:46:31
NME

Base Information

Drug NameHBV replication inhibitors (GVK Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAragen Life Sciences Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAragen Life Sciences Pvt Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A